Analyst upgrades, downgrades and initiations: CI, CCE, JBLU, LIZ, LLL


Analyst upgrades:

  • Oppenheimer upgraded FTI Consulting (NYSE:FCN) to Outperform from Perform on expectations the stock will outperform in the second half of 2009 due to easier comparisons and a "deeper and longer" restructuring cycle. The firm has a $62 target on shares.
  • Citigroup upgraded Cigna (NYSE:CI) to Hold from Sell to reflect reduced balance sheet risk following the company's capital raise and the potential for a PBM sale. The firm raised its target price to $23 from $13.
  • Goldman expects Coca-Cola Enterprises (NYSE:CCE) to benefit from favorable soda demand and lower commodity costs. The firm upgraded shares to Conviction Buy from Buy and has a $20 target on the stock.
  • Novellus (NASDAQ:NVLS) was raised to Buy from Neutral at Bank of America/Merrill.
  • CME Group (NASDAQ:CME) was upgraded at JP Morgan to Neutral from Underweight.
  • Allegiant (NASDAQ:ALGT) was upgraded to Overweight from Equal Weight at Morgan Stanley.

Analyst downgrades:

  • Jefferies downgraded AstraZeneca (NYSE:AZN) to Underperform from Hold as it believes consensus estimates beyond 2010 are too high and that shares are overvalued at current levels.
  • Goldman removed Liz Claiborne (NYSE:LIZ) from its Conviction Buy List, cutting shares to Buy from Conviction Buy, due to the slower ramp in the company's EPS recovery. Despite the downgrade, the firm raised their price target to $7.50 from $7.
  • Credit Suisse downgraded Louisiana Pacific (NYSE:LPX) to Underperform from Neutral and lowered their target to $4 from $5. The firm downgraded shares due to the company's recall of 48M linear feet of composite decking after reports of injuries. As a result, they expect the company to have negative free-cash flow into 2010.
  • Pioneer Drilling (AMEX:PDC) was downgraded to Sell from Neutral at UBS.
  • JetBlue (NASDAQ:JBLU) was downgraded to Equal Weight from Overweight at Morgan Stanley.
  • Alcatel-Lucent (NYSE:ALU) was downgraded to Reduce from Neutral at WestLB.

Analyst initiations:

  • Soleil finds Valeant (NYSE:VRX) overvalued given deteriorating underlying trends for its core branded business. The firm started shares with a Sell rating and $14 target.
  • Equinix (NASDAQ:EQIX) was initiated at Morgan Stanley with an Equal Weight rating.
  • Praxair (NYSE:PX) and Air Products (NYSE:APD) were initiated with Buy ratings and an $84 target and $75 target, respectively.
  • L-3 Comm (NYSE:LLL) was assumed with a Hold rating at Morgan Joseph.
  • Navigant Consulting (NYSE:NCI) was initiated with a Perform rating at Oppenheimer.

Reader Comments (Page 1 of 1)

Symbol Lookup
IndexesChangePrice
DJIA+49.5712,850.80
NASDAQ+24.322,928.20
S&P 500+7.731,350.37

Last updated: February 13, 2012: 10:23 AM

Hot Stocks

General Electric

18.935+0.06(+0.32)

Alcoa

10.32+0.03(+0.29)

Apple Inc

499.29+5.87(+1.19)

Google Inc 'A'

612.61+6.70(+1.11)

Bank of America

8.24+0.17(+2.11)

Wal-Mart Stores

61.87-0.03(-0.05)

Exxon Mobil Corp

83.96+0.16(+0.19)

Ford

12.56+0.12(+0.96)

Citigroup

33.43+0.505(+1.53)

IBM

192.75+0.33(+0.17)

Yahoo

16.09-0.05(-0.31)

Starbucks

48.95+0.13(+0.27)

Microsoft

30.61+0.115(+0.38)

Home Depot

45.61+0.28(+0.62)

DailyFinance Headlines

Benzinga Headlines

TheFlyOnTheWall.com Headlines

BioHealth Investor Headlines

WalletPop Headlines

DailyFinance BlackBerry App

My Portfolios

Track your stocks here!

Find out why more people track their portfolios on AOL Money & Finance then anywhere else.

BloggingStocks Partners

More from AOL Money & Finance

BioHealth Investor Headlines

Page Loaded in 1329146634537 ms.